Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
DarioHealth Corp. issued 2,713,180 shares of common stock of common stock to purchasers in a private placement for $6.45 per share.
- Security
- common stock
- Shares
- 2,713,180 shares of common stock
- Purchaser
- purchasers in a private placement
- Consideration
- $6.45 per share
Exact text from the filing
health market, today announced a private placement for the purchase and sale of 2,713,180 shares of common stock (or common stock equivalents in lieu thereof) at a price of $6.45 per share for expected aggregate gross proceeds of approximately $ 17.5 million, before deducting offering expenses. The closing of the offering is expected to occur on or about
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
DarioHealth Corp.: Amended Series C-1 Certificate of Designation to accelerate mandatory conversion period (effective 2025-09-25).
- Change
- charter amendment
- Effective
- 2025-09-25
Exact text from the filing
On September 25, 2025, the Company, upon obtaining the vote of a majority of the holders of the relevant classes of preferred stock and the approval of the Company’s Board of Directors, filed an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series C-1 Preferred Stock (the “Series C-1 Certificate of Designation”) with the Secretary of State of the State of Delaware. The Series C-1 Certificate of Designation was amended to accelerate the mandatory conversion period of all outstanding shares of such series into shares of the Company’s common stock, or at each holder’s election in pre-funded warrants, effective as of September 25, 2025.
View on SEC.gov